What Happened?
Watertown, MA-based C4-Therapeutics Resigned William McKee as Interim Chief Financial Officer
About the Company
C4 Therapeutics is pioneering a new class of drugs. C4`s technology platform produces small molecule drugs that harness machinery already present in cells to selectively target disease-relevant proteins for degradation. Our approach has the potential to address a broad range of diseases including cancer, infectious disease, and autoimmune disorders.
About the Person
William McKee is Interim Chief Financial Officer at C4 Therapeutics. Previously, William held various senior HR leadership roles in the industry.
Info Source
News
Short Profile